№ files_lp_4_process_2_79016
File format: docx
Character count: 10423
File size: 1571 KB
Detailed description of a job posting outlining the responsibilities, projects, and target population for a Peer Support Lead focused on hepatitis C and liver health in community and healthcare settings in South West London.
Year:
2026
Region / City:
South West London, United Kingdom
Topic:
Hepatitis C, liver health, peer support
Document Type:
Job description
Organization:
The Hepatitis C Trust
Position:
Peer Support Lead
Reporting To:
South West London Peer Coordinator
Work Base:
Home-based, regional outreach
Hours per Week:
37.5
Key Responsibilities:
Peer education, workforce development, buddy scheme, blood borne virus testing, liver health promotion
Target Audience:
Community outreach workers, people who inject drugs, marginalised populations
Relevant Projects:
Follow Me Project, Community Liver Health Bus, Community Liver Surveillance Project
Required Skills:
Peer support, training delivery, communication with healthcare and community services, administrative duties
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Year:
2026
Region:
United States
Document Type:
Policy Procedure
Organization:
Public Housing Agency (PHA)
Programs:
Public Housing (PH), Project-Based Voucher (PBV), Housing Choice Voucher (HCV)
Subject:
Interim Rent Adjustments
Effective Date:
Specified per adjustment section
Applicable Regulations:
24 CFR § 5.630, § 960.253(f)
Target Audience:
Residents participating in PH, PBV, or HCV programs
Year:
2012
Region / City:
Ukraine
Topic:
HCV treatment access, harm reduction, public health policy
Document Type:
Research paper
Organization / Institution:
Alliance
Author:
Ludmila Maistat, Pavlo Skala, Tatiana Barnard, Nataliia Kravchenko
Target Audience:
Public health professionals, policymakers, medical community
Period of Action:
2012 and ongoing
Date of Approval:
Not specified
Date of Changes:
Not specified
Description:
This document details the outcomes of large-scale advocacy and demonstration treatment programs aimed at improving access to HCV treatment for people who inject drugs (PWIDs) in Ukraine, with a focus on policy changes and the integration of HCV treatment into harm reduction programs.
Year:
2014
Region / city:
Calgary, Alberta, Canada
Theme:
Hepatitis C, Healthcare Outreach
Document type:
Research report
Organization / institution:
University of Calgary, CUPS
Author:
Macphail GLP, Watson LJ, Edwards RL
Target audience:
Healthcare professionals, Public health workers, Community health organizations
Period of validity:
2014 - present
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
A research report documenting the implementation of Fibroscan Days to increase patient engagement and improve access to care for Hepatitis C in an inner-city health centre.
Year:
2013
Region / City:
Australia
Topic:
Hepatitis C Virus Screening
Document Type:
Research Study / Surveillance Report
Institution:
The Kirby Institute; Western Australia Department of Health; Queensland Health; Australian Injecting & Illicit Drug Users League; Tasmanian Department of Health and Human Services
Authors:
J. Iversen, J. Bevan, R. Kemp, A. Madden, F. Smith, L. Maher
Target Population:
People Who Inject Drugs (PWID)
Data Source:
Australian Needle and Syringe Program Survey (ANSPS)
Methodology:
Self-reported diagnostic screening, multivariable logistic regression
Key Findings:
Screening uptake, RNA/genotype testing rates, factors associated with testing
Year:
2017
Region / City:
Oxford, UK
Subject:
Oncology, TNM Classification
Document Type:
Appendix
Institution:
Wiley-Blackwell
Author:
Brierley JD, Gospodarowicz MK, Wittekind C
Target Audience:
Medical professionals, oncologists, pathologists
Period of validity:
1 January 2018 and onward
Date of Approval:
Not specified
Date of Revisions:
Not specified
Year:
2023
Region / City:
United States
Theme:
Transplantation
Document Type:
Instructional Guidelines
Organ / Institution:
OPTN
Author:
Not specified
Target Audience:
Healthcare providers, transplant centers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / city:
Global
Theme:
Liver function tests, Metabolic Syndrome, Hepatology
Document type:
Medical guidelines
Organization / institution:
National Health Service (NHS)
Author:
Not specified
Target audience:
Healthcare professionals
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Context:
This document provides a detailed algorithm for managing abnormal liver function tests (LFTs), focusing on potential liver diseases, metabolic syndrome, and associated conditions, aimed at guiding clinical decisions for healthcare providers.
Organization:
National Institute for Health and Care Excellence
Centre:
Centre for Health Technology Evaluation
Committee:
Diagnostics Advisory Committee
Document type:
Meeting minutes
Meeting date:
28 September 2022
Location:
Via Zoom
Session type:
Open session
Chair:
Brian Shine
Topic:
Evaluation of MRI-based technologies for assessing non-alcoholic fatty liver disease
Participants:
Committee members, NICE staff, external assessment groups, external assessment centres, specialist committee members, experts, observers
Conflicts of interest:
Declarations recorded
Approval status:
Minutes confirmed
Note:
Year
Topic:
Cancer diagnosis
Document Type:
Audit tool
Target Audience:
Healthcare professionals involved in cancer diagnostics
Contextual description:
A diagnostic audit tool for evaluating and improving the capacity of healthcare services in delivering a timed HPB cancer diagnostic pathway.
Year:
2023
Region / City:
Not specified
Subject:
Pathology, Liver Surgery, Liver Explants
Document Type:
Procedural Guide
Institution:
Not specified
Author:
Not specified
Target Audience:
Pathologists, Medical Professionals
Effective Period:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2023
Region / City:
Wuhan, China
Topic:
Gene expression, liver fibrosis, HCC
Document Type:
Research Article
Organization / Institution:
Zhongnan Hospital of Wuhan University, Wuhan University
Author:
Not specified
Target Audience:
Researchers, clinicians, medical professionals
Duration:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Context
Note:
Year
Subject:
Alcohol-associated liver disease, Phagocytosis, Macrophages, MLKL
Document type:
Supplemental Materials
Author:
Xiaoqin Wu, Xiude Fan, Megan R. McMullen, Tatsunori Miyata, Adam Kim, Vai Pathak, Jianguo Wu, Le Z. Day, Josiah E. Hardesty, Nicole Welch, Jaividhya Dasarathy, Daniela S. Allende, Arthur J. McCullough, Jon M. Jacobs, Daniel M. Rotroff, Srinivasan Dasarathy, Laura E. Nagy
Target audience:
Researchers, Medical professionals
Year:
2023
Region / city:
Sweden, Denmark, Norway
Topic:
Glucagon-like peptide-1 (GLP-1) receptor agonists, liver events, cohort study
Document type:
Research study
Organization / institution:
None specified
Author:
Engström et al.
Target audience:
Medical researchers, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2026
Region / city:
Trafford
Topic:
Liver disease prevention, Health campaign
Document type:
Toolkit
Organization:
Trafford Council, British Liver Trust, Drinkaware, British Heart Foundation
Author:
Suzanne, Cllr Jo Harding
Target audience:
General public, social media users
Period of validity:
January - February 2026
Approval date:
January 2026
Revision date:
N/A
Name:
Mr Wong
Age:
45
Gender:
Male
Diagnosis:
Non-Alcoholic Fatty Liver Disease (NAFLD)
Occupation:
Software Developer
Document Type:
Clinical interview and dietary assessment report
Medical Condition:
Non-Alcoholic Fatty Liver Disease
Assessment Focus:
Dietary habits and lifestyle changes
Pre-Diagnosis Diet Characteristics:
High intake of refined carbohydrates, sugars, saturated and trans fats; frequent sugary drinks and alcohol consumption
Post-Diagnosis Diet Characteristics:
Increased intake of whole grains, lean proteins, healthy fats, and fibre; reduced refined sugars, saturated fats, sugary drinks, and alcohol
Lifestyle Factors:
Physical activity and weight management
Recommendations:
Dietary modification, increased omega-3 intake, portion control, increased physical activity
Plan:
Follow-up appointments, dietitian referral, educational materials, personalized exercise plan
Includes:
Patient reflection statement
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Organisations:
European Society for Paediatric Gastroenterology Hepatology and Nutrition; European Association for the Study of the Liver
Type of document:
Joint statement
Thematic area:
Paediatric hepatology; fatty liver disease; NAFLD; MAFLD
Subject:
Diagnostic approach to hepatic steatosis in children and adolescents
Target audience:
Paediatricians; hepatologists; clinicians
Geographical scope:
Europe
Key terms:
Non-alcoholic fatty liver disease (NAFLD); metabolic dysfunction-associated fatty liver disease (MAFLD); insulin resistance; metabolic syndrome; Wilson’s disease; autoimmune hepatitis
Referenced process:
Global multi-stakeholder Delphi consensus on nomenclature and definition of fatty liver disease
Correspondence:
[email protected]
Year:
2023
Region / city:
N/A
Topic:
Hepatectomy procedure and postoperative care
Document type:
Medical protocol
Organization:
N/A
Author:
N/A
Target audience:
Healthcare professionals, surgeons, anesthesiologists
Effective period:
N/A
Approval date:
N/A
Amendment date:
N/A